- call +1-201-465-4211
- email sales@marketquest.biz
- Call +1-201-465-4211
- Email: sales@marketquest.biz
Neuraminidase enzymes are glycoside hydrolase enzymes that cleave (cut) the glycosidic linkages of neuraminic acids. The viral neuraminidases are frequently used as antigenic determinants found on the surface of the influenza virus.
According to our latest study, the global Influenza NA Inhibitor market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Influenza NA Inhibitor market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Influenza NA Inhibitor market size and forecasts, in consumption value ($ Million), sales quantity (Kilotons), and average selling prices (US$/Kg), 2018-2029
Global Influenza NA Inhibitor market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Kilotons), and average selling prices (US$/Kg), 2018-2029
Global Influenza NA Inhibitor market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Kilotons), and average selling prices (US$/Kg), 2018-2029
Global Influenza NA Inhibitor market shares of main players, shipments in revenue ($ Million), sales quantity (Kilotons), and ASP (US$/Kg), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Influenza NA Inhibitor
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Influenza NA Inhibitor market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Green Cross, Roche, GlaxoSmithKline, Henan DaKen Chemical and ATK Chemical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Influenza NA Inhibitor market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Zanamivir
Oseltamivir
Peramivir
Market segment by Application
Influenza A Treatment
Influenza B Treatment
Major players covered
Green Cross
Roche
GlaxoSmithKline
Henan DaKen Chemical
ATK Chemical
Chemwill Asia Co.,Ltd.
Shionogi Co.
NeoPharm
Moksha8 Pharma
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Influenza NA Inhibitor product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Influenza NA Inhibitor, with price, sales, revenue and global market share of Influenza NA Inhibitor from 2018 to 2023.
Chapter 3, the Influenza NA Inhibitor competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Influenza NA Inhibitor breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Influenza NA Inhibitor market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Influenza NA Inhibitor.
Chapter 14 and 15, to describe Influenza NA Inhibitor sales channel, distributors, customers, research findings and conclusion.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Product Overview and Scope of Influenza NA Inhibitor
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Influenza NA Inhibitor Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Zanamivir
1.3.3 Oseltamivir
1.3.4 Peramivir
1.4 Market Analysis by Application
1.4.1 Overview: Global Influenza NA Inhibitor Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Influenza A Treatment
1.4.3 Influenza B Treatment
1.5 Global Influenza NA Inhibitor Market Size & Forecast
1.5.1 Global Influenza NA Inhibitor Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Influenza NA Inhibitor Sales Quantity (2018-2029)
1.5.3 Global Influenza NA Inhibitor Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Green Cross
2.1.1 Green Cross Details
2.1.2 Green Cross Major Business
2.1.3 Green Cross Influenza NA Inhibitor Product and Services
2.1.4 Green Cross Influenza NA Inhibitor Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Green Cross Recent Developments/Updates
2.2 Roche
2.2.1 Roche Details
2.2.2 Roche Major Business
2.2.3 Roche Influenza NA Inhibitor Product and Services
2.2.4 Roche Influenza NA Inhibitor Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Roche Recent Developments/Updates
2.3 GlaxoSmithKline
2.3.1 GlaxoSmithKline Details
2.3.2 GlaxoSmithKline Major Business
2.3.3 GlaxoSmithKline Influenza NA Inhibitor Product and Services
2.3.4 GlaxoSmithKline Influenza NA Inhibitor Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 GlaxoSmithKline Recent Developments/Updates
2.4 Henan DaKen Chemical
2.4.1 Henan DaKen Chemical Details
2.4.2 Henan DaKen Chemical Major Business
2.4.3 Henan DaKen Chemical Influenza NA Inhibitor Product and Services
2.4.4 Henan DaKen Chemical Influenza NA Inhibitor Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Henan DaKen Chemical Recent Developments/Updates
2.5 ATK Chemical
2.5.1 ATK Chemical Details
2.5.2 ATK Chemical Major Business
2.5.3 ATK Chemical Influenza NA Inhibitor Product and Services
2.5.4 ATK Chemical Influenza NA Inhibitor Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 ATK Chemical Recent Developments/Updates
2.6 Chemwill Asia Co.,Ltd.
2.6.1 Chemwill Asia Co.,Ltd. Details
2.6.2 Chemwill Asia Co.,Ltd. Major Business
2.6.3 Chemwill Asia Co.,Ltd. Influenza NA Inhibitor Product and Services
2.6.4 Chemwill Asia Co.,Ltd. Influenza NA Inhibitor Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Chemwill Asia Co.,Ltd. Recent Developments/Updates
2.7 Shionogi Co.
2.7.1 Shionogi Co. Details
2.7.2 Shionogi Co. Major Business
2.7.3 Shionogi Co. Influenza NA Inhibitor Product and Services
2.7.4 Shionogi Co. Influenza NA Inhibitor Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Shionogi Co. Recent Developments/Updates
2.8 NeoPharm
2.8.1 NeoPharm Details
2.8.2 NeoPharm Major Business
2.8.3 NeoPharm Influenza NA Inhibitor Product and Services
2.8.4 NeoPharm Influenza NA Inhibitor Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 NeoPharm Recent Developments/Updates
2.9 Moksha8 Pharma
2.9.1 Moksha8 Pharma Details
2.9.2 Moksha8 Pharma Major Business
2.9.3 Moksha8 Pharma Influenza NA Inhibitor Product and Services
2.9.4 Moksha8 Pharma Influenza NA Inhibitor Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Moksha8 Pharma Recent Developments/Updates
3 Competitive Environment: Influenza NA Inhibitor by Manufacturer
3.1 Global Influenza NA Inhibitor Sales Quantity by Manufacturer (2018-2023)
3.2 Global Influenza NA Inhibitor Revenue by Manufacturer (2018-2023)
3.3 Global Influenza NA Inhibitor Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Influenza NA Inhibitor by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Influenza NA Inhibitor Manufacturer Market Share in 2022
3.4.2 Top 6 Influenza NA Inhibitor Manufacturer Market Share in 2022
3.5 Influenza NA Inhibitor Market: Overall Company Footprint Analysis
3.5.1 Influenza NA Inhibitor Market: Region Footprint
3.5.2 Influenza NA Inhibitor Market: Company Product Type Footprint
3.5.3 Influenza NA Inhibitor Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Influenza NA Inhibitor Market Size by Region
4.1.1 Global Influenza NA Inhibitor Sales Quantity by Region (2018-2029)
4.1.2 Global Influenza NA Inhibitor Consumption Value by Region (2018-2029)
4.1.3 Global Influenza NA Inhibitor Average Price by Region (2018-2029)
4.2 North America Influenza NA Inhibitor Consumption Value (2018-2029)
4.3 Europe Influenza NA Inhibitor Consumption Value (2018-2029)
4.4 Asia-Pacific Influenza NA Inhibitor Consumption Value (2018-2029)
4.5 South America Influenza NA Inhibitor Consumption Value (2018-2029)
4.6 Middle East and Africa Influenza NA Inhibitor Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Influenza NA Inhibitor Sales Quantity by Type (2018-2029)
5.2 Global Influenza NA Inhibitor Consumption Value by Type (2018-2029)
5.3 Global Influenza NA Inhibitor Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Influenza NA Inhibitor Sales Quantity by Application (2018-2029)
6.2 Global Influenza NA Inhibitor Consumption Value by Application (2018-2029)
6.3 Global Influenza NA Inhibitor Average Price by Application (2018-2029)
7 North America
7.1 North America Influenza NA Inhibitor Sales Quantity by Type (2018-2029)
7.2 North America Influenza NA Inhibitor Sales Quantity by Application (2018-2029)
7.3 North America Influenza NA Inhibitor Market Size by Country
7.3.1 North America Influenza NA Inhibitor Sales Quantity by Country (2018-2029)
7.3.2 North America Influenza NA Inhibitor Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Influenza NA Inhibitor Sales Quantity by Type (2018-2029)
8.2 Europe Influenza NA Inhibitor Sales Quantity by Application (2018-2029)
8.3 Europe Influenza NA Inhibitor Market Size by Country
8.3.1 Europe Influenza NA Inhibitor Sales Quantity by Country (2018-2029)
8.3.2 Europe Influenza NA Inhibitor Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Influenza NA Inhibitor Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Influenza NA Inhibitor Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Influenza NA Inhibitor Market Size by Region
9.3.1 Asia-Pacific Influenza NA Inhibitor Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Influenza NA Inhibitor Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Influenza NA Inhibitor Sales Quantity by Type (2018-2029)
10.2 South America Influenza NA Inhibitor Sales Quantity by Application (2018-2029)
10.3 South America Influenza NA Inhibitor Market Size by Country
10.3.1 South America Influenza NA Inhibitor Sales Quantity by Country (2018-2029)
10.3.2 South America Influenza NA Inhibitor Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Influenza NA Inhibitor Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Influenza NA Inhibitor Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Influenza NA Inhibitor Market Size by Country
11.3.1 Middle East & Africa Influenza NA Inhibitor Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Influenza NA Inhibitor Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Influenza NA Inhibitor Market Drivers
12.2 Influenza NA Inhibitor Market Restraints
12.3 Influenza NA Inhibitor Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Influenza NA Inhibitor and Key Manufacturers
13.2 Manufacturing Costs Percentage of Influenza NA Inhibitor
13.3 Influenza NA Inhibitor Production Process
13.4 Influenza NA Inhibitor Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Influenza NA Inhibitor Typical Distributors
14.3 Influenza NA Inhibitor Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
List of Tables
Table 1. Global Influenza NA Inhibitor Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Influenza NA Inhibitor Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Green Cross Basic Information, Manufacturing Base and Competitors
Table 4. Green Cross Major Business
Table 5. Green Cross Influenza NA Inhibitor Product and Services
Table 6. Green Cross Influenza NA Inhibitor Sales Quantity (Kilotons), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Green Cross Recent Developments/Updates
Table 8. Roche Basic Information, Manufacturing Base and Competitors
Table 9. Roche Major Business
Table 10. Roche Influenza NA Inhibitor Product and Services
Table 11. Roche Influenza NA Inhibitor Sales Quantity (Kilotons), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Roche Recent Developments/Updates
Table 13. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 14. GlaxoSmithKline Major Business
Table 15. GlaxoSmithKline Influenza NA Inhibitor Product and Services
Table 16. GlaxoSmithKline Influenza NA Inhibitor Sales Quantity (Kilotons), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. GlaxoSmithKline Recent Developments/Updates
Table 18. Henan DaKen Chemical Basic Information, Manufacturing Base and Competitors
Table 19. Henan DaKen Chemical Major Business
Table 20. Henan DaKen Chemical Influenza NA Inhibitor Product and Services
Table 21. Henan DaKen Chemical Influenza NA Inhibitor Sales Quantity (Kilotons), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Henan DaKen Chemical Recent Developments/Updates
Table 23. ATK Chemical Basic Information, Manufacturing Base and Competitors
Table 24. ATK Chemical Major Business
Table 25. ATK Chemical Influenza NA Inhibitor Product and Services
Table 26. ATK Chemical Influenza NA Inhibitor Sales Quantity (Kilotons), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. ATK Chemical Recent Developments/Updates
Table 28. Chemwill Asia Co.,Ltd. Basic Information, Manufacturing Base and Competitors
Table 29. Chemwill Asia Co.,Ltd. Major Business
Table 30. Chemwill Asia Co.,Ltd. Influenza NA Inhibitor Product and Services
Table 31. Chemwill Asia Co.,Ltd. Influenza NA Inhibitor Sales Quantity (Kilotons), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Chemwill Asia Co.,Ltd. Recent Developments/Updates
Table 33. Shionogi Co. Basic Information, Manufacturing Base and Competitors
Table 34. Shionogi Co. Major Business
Table 35. Shionogi Co. Influenza NA Inhibitor Product and Services
Table 36. Shionogi Co. Influenza NA Inhibitor Sales Quantity (Kilotons), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Shionogi Co. Recent Developments/Updates
Table 38. NeoPharm Basic Information, Manufacturing Base and Competitors
Table 39. NeoPharm Major Business
Table 40. NeoPharm Influenza NA Inhibitor Product and Services
Table 41. NeoPharm Influenza NA Inhibitor Sales Quantity (Kilotons), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. NeoPharm Recent Developments/Updates
Table 43. Moksha8 Pharma Basic Information, Manufacturing Base and Competitors
Table 44. Moksha8 Pharma Major Business
Table 45. Moksha8 Pharma Influenza NA Inhibitor Product and Services
Table 46. Moksha8 Pharma Influenza NA Inhibitor Sales Quantity (Kilotons), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Moksha8 Pharma Recent Developments/Updates
Table 48. Global Influenza NA Inhibitor Sales Quantity by Manufacturer (2018-2023) & (Kilotons)
Table 49. Global Influenza NA Inhibitor Revenue by Manufacturer (2018-2023) & (USD Million)
Table 50. Global Influenza NA Inhibitor Average Price by Manufacturer (2018-2023) & (US$/Kg)
Table 51. Market Position of Manufacturers in Influenza NA Inhibitor, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 52. Head Office and Influenza NA Inhibitor Production Site of Key Manufacturer
Table 53. Influenza NA Inhibitor Market: Company Product Type Footprint
Table 54. Influenza NA Inhibitor Market: Company Product Application Footprint
Table 55. Influenza NA Inhibitor New Market Entrants and Barriers to Market Entry
Table 56. Influenza NA Inhibitor Mergers, Acquisition, Agreements, and Collaborations
Table 57. Global Influenza NA Inhibitor Sales Quantity by Region (2018-2023) & (Kilotons)
Table 58. Global Influenza NA Inhibitor Sales Quantity by Region (2024-2029) & (Kilotons)
Table 59. Global Influenza NA Inhibitor Consumption Value by Region (2018-2023) & (USD Million)
Table 60. Global Influenza NA Inhibitor Consumption Value by Region (2024-2029) & (USD Million)
Table 61. Global Influenza NA Inhibitor Average Price by Region (2018-2023) & (US$/Kg)
Table 62. Global Influenza NA Inhibitor Average Price by Region (2024-2029) & (US$/Kg)
Table 63. Global Influenza NA Inhibitor Sales Quantity by Type (2018-2023) & (Kilotons)
Table 64. Global Influenza NA Inhibitor Sales Quantity by Type (2024-2029) & (Kilotons)
Table 65. Global Influenza NA Inhibitor Consumption Value by Type (2018-2023) & (USD Million)
Table 66. Global Influenza NA Inhibitor Consumption Value by Type (2024-2029) & (USD Million)
Table 67. Global Influenza NA Inhibitor Average Price by Type (2018-2023) & (US$/Kg)
Table 68. Global Influenza NA Inhibitor Average Price by Type (2024-2029) & (US$/Kg)
Table 69. Global Influenza NA Inhibitor Sales Quantity by Application (2018-2023) & (Kilotons)
Table 70. Global Influenza NA Inhibitor Sales Quantity by Application (2024-2029) & (Kilotons)
Table 71. Global Influenza NA Inhibitor Consumption Value by Application (2018-2023) & (USD Million)
Table 72. Global Influenza NA Inhibitor Consumption Value by Application (2024-2029) & (USD Million)
Table 73. Global Influenza NA Inhibitor Average Price by Application (2018-2023) & (US$/Kg)
Table 74. Global Influenza NA Inhibitor Average Price by Application (2024-2029) & (US$/Kg)
Table 75. North America Influenza NA Inhibitor Sales Quantity by Type (2018-2023) & (Kilotons)
Table 76. North America Influenza NA Inhibitor Sales Quantity by Type (2024-2029) & (Kilotons)
Table 77. North America Influenza NA Inhibitor Sales Quantity by Application (2018-2023) & (Kilotons)
Table 78. North America Influenza NA Inhibitor Sales Quantity by Application (2024-2029) & (Kilotons)
Table 79. North America Influenza NA Inhibitor Sales Quantity by Country (2018-2023) & (Kilotons)
Table 80. North America Influenza NA Inhibitor Sales Quantity by Country (2024-2029) & (Kilotons)
Table 81. North America Influenza NA Inhibitor Consumption Value by Country (2018-2023) & (USD Million)
Table 82. North America Influenza NA Inhibitor Consumption Value by Country (2024-2029) & (USD Million)
Table 83. Europe Influenza NA Inhibitor Sales Quantity by Type (2018-2023) & (Kilotons)
Table 84. Europe Influenza NA Inhibitor Sales Quantity by Type (2024-2029) & (Kilotons)
Table 85. Europe Influenza NA Inhibitor Sales Quantity by Application (2018-2023) & (Kilotons)
Table 86. Europe Influenza NA Inhibitor Sales Quantity by Application (2024-2029) & (Kilotons)
Table 87. Europe Influenza NA Inhibitor Sales Quantity by Country (2018-2023) & (Kilotons)
Table 88. Europe Influenza NA Inhibitor Sales Quantity by Country (2024-2029) & (Kilotons)
Table 89. Europe Influenza NA Inhibitor Consumption Value by Country (2018-2023) & (USD Million)
Table 90. Europe Influenza NA Inhibitor Consumption Value by Country (2024-2029) & (USD Million)
Table 91. Asia-Pacific Influenza NA Inhibitor Sales Quantity by Type (2018-2023) & (Kilotons)
Table 92. Asia-Pacific Influenza NA Inhibitor Sales Quantity by Type (2024-2029) & (Kilotons)
Table 93. Asia-Pacific Influenza NA Inhibitor Sales Quantity by Application (2018-2023) & (Kilotons)
Table 94. Asia-Pacific Influenza NA Inhibitor Sales Quantity by Application (2024-2029) & (Kilotons)
Table 95. Asia-Pacific Influenza NA Inhibitor Sales Quantity by Region (2018-2023) & (Kilotons)
Table 96. Asia-Pacific Influenza NA Inhibitor Sales Quantity by Region (2024-2029) & (Kilotons)
Table 97. Asia-Pacific Influenza NA Inhibitor Consumption Value by Region (2018-2023) & (USD Million)
Table 98. Asia-Pacific Influenza NA Inhibitor Consumption Value by Region (2024-2029) & (USD Million)
Table 99. South America Influenza NA Inhibitor Sales Quantity by Type (2018-2023) & (Kilotons)
Table 100. South America Influenza NA Inhibitor Sales Quantity by Type (2024-2029) & (Kilotons)
Table 101. South America Influenza NA Inhibitor Sales Quantity by Application (2018-2023) & (Kilotons)
Table 102. South America Influenza NA Inhibitor Sales Quantity by Application (2024-2029) & (Kilotons)
Table 103. South America Influenza NA Inhibitor Sales Quantity by Country (2018-2023) & (Kilotons)
Table 104. South America Influenza NA Inhibitor Sales Quantity by Country (2024-2029) & (Kilotons)
Table 105. South America Influenza NA Inhibitor Consumption Value by Country (2018-2023) & (USD Million)
Table 106. South America Influenza NA Inhibitor Consumption Value by Country (2024-2029) & (USD Million)
Table 107. Middle East & Africa Influenza NA Inhibitor Sales Quantity by Type (2018-2023) & (Kilotons)
Table 108. Middle East & Africa Influenza NA Inhibitor Sales Quantity by Type (2024-2029) & (Kilotons)
Table 109. Middle East & Africa Influenza NA Inhibitor Sales Quantity by Application (2018-2023) & (Kilotons)
Table 110. Middle East & Africa Influenza NA Inhibitor Sales Quantity by Application (2024-2029) & (Kilotons)
Table 111. Middle East & Africa Influenza NA Inhibitor Sales Quantity by Region (2018-2023) & (Kilotons)
Table 112. Middle East & Africa Influenza NA Inhibitor Sales Quantity by Region (2024-2029) & (Kilotons)
Table 113. Middle East & Africa Influenza NA Inhibitor Consumption Value by Region (2018-2023) & (USD Million)
Table 114. Middle East & Africa Influenza NA Inhibitor Consumption Value by Region (2024-2029) & (USD Million)
Table 115. Influenza NA Inhibitor Raw Material
Table 116. Key Manufacturers of Influenza NA Inhibitor Raw Materials
Table 117. Influenza NA Inhibitor Typical Distributors
Table 118. Influenza NA Inhibitor Typical Customers
List of Figures
Figure 1. Influenza NA Inhibitor Picture
Figure 2. Global Influenza NA Inhibitor Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Influenza NA Inhibitor Consumption Value Market Share by Type in 2022
Figure 4. Zanamivir Examples
Figure 5. Oseltamivir Examples
Figure 6. Peramivir Examples
Figure 7. Global Influenza NA Inhibitor Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 8. Global Influenza NA Inhibitor Consumption Value Market Share by Application in 2022
Figure 9. Influenza A Treatment Examples
Figure 10. Influenza B Treatment Examples
Figure 11. Global Influenza NA Inhibitor Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global Influenza NA Inhibitor Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global Influenza NA Inhibitor Sales Quantity (2018-2029) & (Kilotons)
Figure 14. Global Influenza NA Inhibitor Average Price (2018-2029) & (US$/Kg)
Figure 15. Global Influenza NA Inhibitor Sales Quantity Market Share by Manufacturer in 2022
Figure 16. Global Influenza NA Inhibitor Consumption Value Market Share by Manufacturer in 2022
Figure 17. Producer Shipments of Influenza NA Inhibitor by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 18. Top 3 Influenza NA Inhibitor Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Top 6 Influenza NA Inhibitor Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Global Influenza NA Inhibitor Sales Quantity Market Share by Region (2018-2029)
Figure 21. Global Influenza NA Inhibitor Consumption Value Market Share by Region (2018-2029)
Figure 22. North America Influenza NA Inhibitor Consumption Value (2018-2029) & (USD Million)
Figure 23. Europe Influenza NA Inhibitor Consumption Value (2018-2029) & (USD Million)
Figure 24. Asia-Pacific Influenza NA Inhibitor Consumption Value (2018-2029) & (USD Million)
Figure 25. South America Influenza NA Inhibitor Consumption Value (2018-2029) & (USD Million)
Figure 26. Middle East & Africa Influenza NA Inhibitor Consumption Value (2018-2029) & (USD Million)
Figure 27. Global Influenza NA Inhibitor Sales Quantity Market Share by Type (2018-2029)
Figure 28. Global Influenza NA Inhibitor Consumption Value Market Share by Type (2018-2029)
Figure 29. Global Influenza NA Inhibitor Average Price by Type (2018-2029) & (US$/Kg)
Figure 30. Global Influenza NA Inhibitor Sales Quantity Market Share by Application (2018-2029)
Figure 31. Global Influenza NA Inhibitor Consumption Value Market Share by Application (2018-2029)
Figure 32. Global Influenza NA Inhibitor Average Price by Application (2018-2029) & (US$/Kg)
Figure 33. North America Influenza NA Inhibitor Sales Quantity Market Share by Type (2018-2029)
Figure 34. North America Influenza NA Inhibitor Sales Quantity Market Share by Application (2018-2029)
Figure 35. North America Influenza NA Inhibitor Sales Quantity Market Share by Country (2018-2029)
Figure 36. North America Influenza NA Inhibitor Consumption Value Market Share by Country (2018-2029)
Figure 37. United States Influenza NA Inhibitor Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Canada Influenza NA Inhibitor Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Mexico Influenza NA Inhibitor Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Europe Influenza NA Inhibitor Sales Quantity Market Share by Type (2018-2029)
Figure 41. Europe Influenza NA Inhibitor Sales Quantity Market Share by Application (2018-2029)
Figure 42. Europe Influenza NA Inhibitor Sales Quantity Market Share by Country (2018-2029)
Figure 43. Europe Influenza NA Inhibitor Consumption Value Market Share by Country (2018-2029)
Figure 44. Germany Influenza NA Inhibitor Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. France Influenza NA Inhibitor Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. United Kingdom Influenza NA Inhibitor Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Russia Influenza NA Inhibitor Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Italy Influenza NA Inhibitor Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Asia-Pacific Influenza NA Inhibitor Sales Quantity Market Share by Type (2018-2029)
Figure 50. Asia-Pacific Influenza NA Inhibitor Sales Quantity Market Share by Application (2018-2029)
Figure 51. Asia-Pacific Influenza NA Inhibitor Sales Quantity Market Share by Region (2018-2029)
Figure 52. Asia-Pacific Influenza NA Inhibitor Consumption Value Market Share by Region (2018-2029)
Figure 53. China Influenza NA Inhibitor Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Japan Influenza NA Inhibitor Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Korea Influenza NA Inhibitor Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. India Influenza NA Inhibitor Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Southeast Asia Influenza NA Inhibitor Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Australia Influenza NA Inhibitor Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. South America Influenza NA Inhibitor Sales Quantity Market Share by Type (2018-2029)
Figure 60. South America Influenza NA Inhibitor Sales Quantity Market Share by Application (2018-2029)
Figure 61. South America Influenza NA Inhibitor Sales Quantity Market Share by Country (2018-2029)
Figure 62. South America Influenza NA Inhibitor Consumption Value Market Share by Country (2018-2029)
Figure 63. Brazil Influenza NA Inhibitor Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Argentina Influenza NA Inhibitor Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Middle East & Africa Influenza NA Inhibitor Sales Quantity Market Share by Type (2018-2029)
Figure 66. Middle East & Africa Influenza NA Inhibitor Sales Quantity Market Share by Application (2018-2029)
Figure 67. Middle East & Africa Influenza NA Inhibitor Sales Quantity Market Share by Region (2018-2029)
Figure 68. Middle East & Africa Influenza NA Inhibitor Consumption Value Market Share by Region (2018-2029)
Figure 69. Turkey Influenza NA Inhibitor Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Egypt Influenza NA Inhibitor Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Saudi Arabia Influenza NA Inhibitor Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. South Africa Influenza NA Inhibitor Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Influenza NA Inhibitor Market Drivers
Figure 74. Influenza NA Inhibitor Market Restraints
Figure 75. Influenza NA Inhibitor Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of Influenza NA Inhibitor in 2022
Figure 78. Manufacturing Process Analysis of Influenza NA Inhibitor
Figure 79. Influenza NA Inhibitor Industrial Chain
Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
